Marianne Grønlie Guren

• Dijkstra, Esmée A.; Hospers, Geke A.P.; Kranenbarg, Elma Meershoek-Klein; Fleer, Joke; Roodvoets, Annet G.H. & Bahadoer, Renu R. [Show all 18 contributors for this article] (2022). Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer – The RAPIDO trial. Radiotherapy and Oncology. ISSN 0167-8140. 171, p. 69–76. doi: 10.1016/j.radonc.2022.04.013.
• Falk, Philip; Severin, Mira; Berglund, Åke; Guren, Marianne; Hofsli, Eva & Österlund, Pia [Show all 9 contributors for this article] (2022). Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer. Cancer Treatment and Research Communications. ISSN 2468-2942. 31. doi: 10.1016/j.ctarc.2022.100517.
• Franco, Pierfrancesco; Segelov, Eva; Johnsson, Anders; Riechelmann, Rachel; Guren, Marianne & Das, Prajnan [Show all 14 contributors for this article] (2022). A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer. Cancers. ISSN 2072-6694. 14(7). doi: 10.3390/cancers14071697.
• Nilssen, Yngvar; Brustugun, Odd Terje; Eriksen, Morten Tandberg; Guren, Marianne; Haug, Erik Skaaheim & Naume, Bjørn [Show all 8 contributors for this article] (2022). Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016. BMC Cancer. ISSN 1471-2407. doi: 10.1186/s12885-022-09306-9.
• Zaborowski, Alexandra M.; Abdile, Ahmed; Adamina, Michel; Aigner, Felix; D'Allens, Laura & Allmer, Caterina [Show all 221 contributors for this article] (2021). Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review. JAMA Surgery. ISSN 2168-6254. 156(9), p. 865–874. doi: 10.1001/jamasurg.2021.2380.
• Rao, Sheela; Guren, Marianne Grønlie; Khan, K; Brown, Gina; Renehan, Andrew & Steigen, Sonja Eriksson [Show all 9 contributors for this article] (2021). Anal cancer: ESMO clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. ISSN 0923-7534. 32(9), p. 1087–1100. doi: 10.1016/j.annonc.2021.06.015.
• Hamfjord, Julian; Myklebust, Tor Åge; Larsen, Inger Kristin; Kure, Elin Wenche Hegland; Glimelius, Bengt & Guren, Tormod Kyrre [Show all 8 contributors for this article] (2021). Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study. Cancer Epidemiology, Biomarkers and Prevention. ISSN 1055-9965. 31(2), p. 342–351. doi: 10.1158/1055-9965.EPI-21-0555. Full text in Research Archive
• Bruun, Jarle; Eide, Peter Andreas Wold; Bergsland, Christian Holst; Brück, Oscar; Svindland, Aud & Arjama, Mariliina [Show all 13 contributors for this article] (2021). E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Molecular Oncology. ISSN 1574-7891. 00, p. 1–18. doi: 10.1002/1878-0261.13159. Full text in Research Archive
• Guren, Marianne; Sebag-Montefiore, David; Franco, Pierfrancesco; Johnsson, Anders; Segelov, Eva & Deutsch, Eric [Show all 9 contributors for this article] (2021). Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer. Clinical colorectal cancer. ISSN 1533-0028. 20(4), p. 279–287. doi: 10.1016/j.clcc.2021.09.006. Show summary

  Anal cancer is a relatively rare, mostly HPV-related cancer. The curative treatment consists of concurrent chemoradiation delivered with modern radiotherapy techniques. The prognosis for most patients with early localized disease is very favourable; however patients with locally advanced disease and/or HPV negative tumours are at higher risk of locoregional and distant treatment failure. Tailored approaches are presently being investigated to determine the most suitable regimen in terms of radiotherapy dose prescription, target volume selection, normal tissue avoidance, and combination therapy. Metastatic anal cancer is treated with chemotherapy aiming at prolonged survival. The role of immune therapy in the clinical setting is being investigated. There is little knowledge on the biology of anal cancer, and an urgent need for more clinical and translational research dedicated to this disease. In this article, the evidence-base for the current treatment is briefly reviewed, and perspectives on future research needs are high-lighted.

• Rønde, Heidi S.; Kallehauge, Jesper F; Kronborg, Camilla; Nyvang, L; Rekstad, Bernt Louni & Hanekamp, Bettina [Show all 9 contributors for this article] (2021). Intensity modulated proton therapy planning study for organ at risk sparing in rectal cancer re-irradiation. Acta Oncologica. ISSN 0284-186X. 60(11), p. 1436–1439. doi: 10.1080/0284186X.2021.1953139.
• Moosavi, Seyed Hossein; Eide, Peter Andreas Wold; Eilertsen, Ina Andrassy; Brunsell, Tuva Høst; Berg, Kaja Christine Graue & Røsok, Bård Ingvald [Show all 12 contributors for this article] (2021). De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity. Genome Medicine. ISSN 1756-994X. 13, p. 143–143. doi: 10.1186/s13073-021-00956-1. Full text in Research Archive
• Slørdahl, Kathinka; Klotz, Dagmar; Olsen, Jan Åge; Skovlund, Eva; Undseth, Christine & Abildgaard, Heidi L. [Show all 17 contributors for this article] (2021). Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer. Acta Oncologica. ISSN 0284-186X. 60(7), p. 921–930. doi: 10.1080/0284186X.2021.1918763. Full text in Research Archive
• Choudhury, Ananya; Theophanous, Stelios; Lønne, Per-Ivar; Samuel, Robert; Guren, Marianne Grønlie & Berbee, Maaike [Show all 14 contributors for this article] (2021). Predicting outcomes in anal cancer patients using multi-centre data and distributed learning - A proof-of-concept study. Radiotherapy and Oncology. ISSN 0167-8140. 159, p. 183–189. doi: 10.1016/j.radonc.2021.03.013.
• Österman, Erik; Ekström, Joakim; Sjöblom, Tobias; Kørner, Hartwig; Myklebust, Tor Åge & Guren, Marianne [Show all 7 contributors for this article] (2021). Accurate population-based model for individual prediction of colon cancer recurrence. Acta Oncologica. ISSN 0284-186X. 60(10), p. 1241–1249. doi: 10.1080/0284186X.2021.1953138.
• Grøndahl, Aurora Rosvoll; Moe, Yngve Mardal; Kaushal, Christine Kiran; Huynh, Bao Ngoc; Rusten, Espen & Tomic, Oliver [Show all 12 contributors for this article] (2021). Deep learning-based automatic delineation of anal cancer gross tumour volume: a multimodality comparison of CT, PET and MRI. Acta Oncologica. ISSN 0284-186X. 61(1), p. 89–96. doi: 10.1080/0284186X.2021.1994645.
• Nilssen, Yngvar; Eriksen, Morten Tandberg; Guren, Marianne G. & Møller, Bjørn (2021). Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway. BMC Cancer. ISSN 1471-2407. 21(1). doi: 10.1186/s12885-021-08415-1. Full text in Research Archive
• Kryeziu, Kushtrim; Moosavi, Seyed Hossein; Bergsland, Christian Holst; Guren, Marianne; Eide, Peter Andreas Wold & Totland, Max [Show all 11 contributors for this article] (2021). Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases. Journal of Translational Medicine. ISSN 1479-5876. 19:384, p. 1–11. doi: 10.1186/s12967-021-03062-3. Full text in Research Archive
• Torstveit, Ann Helen; Miaskowski, Christine; Løyland, Borghild; Grov, Ellen Karine; Guren, Marianne Grønlie & Ritchie, Christine Seel [Show all 9 contributors for this article] (2021). Common and distinct characteristics associated with self-reported functional status in older patients with cancer receiving chemotherapy. European Journal of Oncology Nursing. ISSN 1462-3889. 54:102033, p. 1–10. doi: 10.1016/j.ejon.2021.102033. Show summary

  ABSTRACT Purpose: Functional impairment has a negative impact on older patients with cancer. Objectives: Evaluate for inter-individual differences in two subjective measures of functional status in older patients (n = 112); to determine which demographic, clinical, and symptom characteristics, and levels of cognitive function, were associated with initial levels and with the trajectory of the two measures. Methods: Functional status was assessed using self-report measures of physical function (PF) and role function (RF) from the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire at the initiation of chemotherapy and at 1, 3, 6, 9, and 12 months after its initiation. Hierarchical linear modeling was used to assess inter-individual differences in and characteristics associated with initial levels and changes in PF and RF. Results: Characteristics associated with decreases in PF at the initiation of chemotherapy were higher numbers of comorbidities and higher depression, pain, and dyspnea scores. For initial levels of poorer RF, lower Karnofsky Performance Status scores and higher pain and fatigue scores were the associated characteristics. Characteristic associated with worse trajectories of PF was not having had surgery. For RF, worse trajectories were associated with lower cognitive function and higher RF at enrollment. Characteristic associated with both lower initial levels and improved trajectories of PF was having lower performance status at enrollment. Conclusions: Older patients undergoing chemotherapy experience reduced functional performance. Characteristics associated with decrements in PF and RF need to be assessed and interventions implemented to maintain and increase functional status in older oncology patients.

• Bahadoer, Renu R.; Bastiaannet, Esther; Claassen, Yvette H.M.; van der Mark, Marianne; van Eycken, Elizabeth & Verbeeck, Julie [Show all 12 contributors for this article] (2021). One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison. European Journal of Surgical Oncology. ISSN 0748-7983. p. 1–10. doi: 10.1016/j.ejso.2021.01.011.
• Torstveit, Ann Helen; Løyland, Borghild; Grov, Ellen Karine; Guren, Marianne; Paul, Steven M. & Ritchie, Christine [Show all 9 contributors for this article] (2021). Distinctions Between Self-Report and Performance-Based Measures of Physical Function in Older Patients Prior to Chemotherapy. Cancer Nursing. ISSN 0162-220X. 44(6), p. E735–E744. doi: 10.1097/ncc.0000000000000964. Show summary

  ABSTRACT Background: The maintenance of physical function (PF) is an extremely important outcome for older adults. Objective: The aims of this study were to, identify differences in subjective and objective measures of PF between younger older adults (YOA, 60-69 years of age) and older adults (OA, ≥70 years of age); compare the PF scores with age-matched samples from the general population; and evaluate for associations between subjective and objective measures of PF. Methods: Patients (n=139) were assessed using subjective (i.e., European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire (QLQ-C30)) and objective (i.e., Short Physical Performance Battery (SPPB)) measures prior to chemotherapy (CTX). Data were analyzed using parametric and nonparametric tests. Results: No differences were found between the two age groups in any of the subjective or objective measures of PF. Compared to the age-matched general population; both YOA and OA had significantly lower scores in both measures of PF. Large effect sizes were found for differences in QLQ-C30 role function, SPPB balance, and SPPB total scores between the YOA group and the age-matched general population samples. Correlations between the subjective and objective measures were low. Conclusions: Older patients with cancer have lower PF than their age matched general population prior to CTX. Longitudinal studies are warranted to evaluate for changes in PF during and following CTX. Implications for Practice: Nurses need to perform routine assessments of PF in older oncology patients prior to CTX. Our findings suggest that SPPB gait speed may be a useful screening measure for PF in older patients.

• Marijnen, Corrie A.M.; Peters, F P; Rödel, Claus; Bujko, K; Haustermans, Karin & Fokas, Emmanouil [Show all 15 contributors for this article] (2020). International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. Radiotherapy and Oncology. ISSN 0167-8140. 148, p. 213–215. doi: 10.1016/j.radonc.2020.03.039.
• Bruun, Jarle; Kryeziu, Kushtrim; Eide, Peter Andreas Wold; Moosavi, Seyed Hossein; Eilertsen, Ina Andrassy & Røsok, Bård Ingvald [Show all 21 contributors for this article] (2020). Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity. Clinical Cancer Research. ISSN 1078-0432. 26(15), p. 4107–4119. doi: 10.1158/1078-0432.CCR-19-3637.
• Breugom, Anne J.; Bastiaannet, Esther; Guren, Marianne; Kørner, Hartwig; Boelens, Petra G. & Dekker, Friedo W. [Show all 11 contributors for this article] (2020). Treatment strategies and overall survival for incurable metastatic colorectal cancer – A EURECCA international comparison including 21,196 patients from the Netherlands and Norway. European Journal of Surgical Oncology. ISSN 0748-7983. 46(6), p. 1167–1173. doi: 10.1016/j.ejso.2020.02.005.
• Rao, Sheela; Sclafani, Francesco; Eng, Cathy; Adams, Richard A; Guren, Marianne & Sebag-Montefiore, David [Show all 21 contributors for this article] (2020). International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct. Journal of Clinical Oncology. ISSN 0732-183X. 38(22), p. 2510–2518. doi: 10.1200/JCO.19.03266.
• Dahl, Olav; Myklebust, Mette Pernille; Dale, Jon Espen; Leon, Otilia; Serup-Hansen, Eva & Jakobsen, Anders [Show all 13 contributors for this article] (2020). Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version. Acta Oncologica. ISSN 0284-186X. 59(9), p. 1016–1023. doi: 10.1080/0284186X.2020.1778180.
• Araghi, Marzieh; Arnold, Melina; Rutherford, Mark J.; Guren, Marianne; Cabasag, Citadel J. & Bardot, Aude [Show all 25 contributors for this article] (2020). Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. ISSN 0017-5749. 70(1), p. 114–126. doi: 10.1136/gutjnl-2020-320625.
• Pilleron, Sophie; Charvat, Hadrien; Araghi, Marzieh; Arnold, Melina; Fidler-Benaoudia, Miranda M. & Bardot, Aude [Show all 20 contributors for this article] (2020). Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. International Journal of Cancer. ISSN 0020-7136. 148(7), p. 1575–1585. doi: 10.1002/ijc.33326.
• Kværner, Ane Sørlie; Harnæs, Helene; Alavi, Dena Helene; Bärebring, Linnea; Henriksen, Hege & Guren, Marianne [Show all 11 contributors for this article] (2020). Bør beregning av cellegiftdose ved tarmkreft baseres på kroppssammensetning? Tidsskrift for Den norske legeforening. ISSN 0029-2001. 140(8), p. 1–10. doi: 10.4045/tidsskr.19.0769.
• Smeby, Jørgen; Kryeziu, Kushtrim; Berg, Kaja Christine Graue; Eilertsen, Ina Andrassy; Eide, Peter Andreas Wold & Johannessen, Bjarne [Show all 11 contributors for this article] (2020). Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity. EBioMedicine. ISSN 2352-3964. 59:102923, p. 1–13. doi: 10.1016/j.ebiom.2020.102923. Full text in Research Archive
• Bergsland, Christian Holst; Bruun, Jarle; Guren, Marianne; Svindland, Aud; Bjørnslett, Merete Pauline & Smeby, Jørgen [Show all 16 contributors for this article] (2020). Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer. ESMO Open. ISSN 2059-7029. 5:e001040(6), p. 1–12. doi: 10.1136/esmoopen-2020-001040. Full text in Research Archive
• Al-Haidari, Ghazwan Ahmed Dhia Eldin; Skovlund, Eva; Undseth, Christine; Rekstad, Bernt Louni; Larsen, Steinar & Åsli, Linn Merete [Show all 9 contributors for this article] (2020). Re-irradiation for recurrent rectal cancer – a single-center experience. Acta Oncologica. ISSN 0284-186X. 59(5), p. 534–540. doi: 10.1080/0284186X.2020.1725111.
• Frydenberg, Hanne; Harsem, Nina Kittelsen; Ofigsbø, Åsa; heid, hanne skoglund; Brandengen, Morten & Kaasa, Stein [Show all 7 contributors for this article] (2020). Chemotherapy During Pregnancy for Advanced Colon Cancer: A Case Report. Clinical colorectal cancer. ISSN 1533-0028. 19(2), p. 141–144. doi: 10.1016/j.clcc.2020.02.013. Full text in Research Archive
• Guren, Marianne Grønlie (2019). The global challenge of colorectal cancer. The Lancet Gastroenterology and Hepatology. ISSN 2468-1253. 4(12), p. 894–895. doi: 10.1016/S2468-1253%2819%2930329-2.
• Ben-Aharon, Irit; Goshen-Lago, Tal; Fontana, Elisa; Smyth, Elizabeth; Guren, Marianne Grønlie & Caballero, Carmela [Show all 7 contributors for this article] (2019). Social networks for young patients with cancer: the time for system agility. The Lancet Oncology. ISSN 1470-2045. 20(6), p. 765–765. doi: 10.1016/S1470-2045%2819%2930346-8.
• Røhrl, Kari; Guren, Marianne; Astrup, Guro Lindviksmoen; Småstuen, Milada C & Rustøen, Tone (2019). High symptom burden is associated with impaired quality of life in colorectal cancer patients during chemotherapy:A prospective longitudinal study. European Journal of Oncology Nursing. ISSN 1462-3889. 44. doi: 10.1016/j.ejon.2019.101679.
• Brunsell, Tuva Høst; Sveen, Anita; Bjørnbeth, Bjørn Atle; Røsok, Bård Ingvald; Danielsen, Stine Aske & Brudvik, Kristoffer Watten [Show all 13 contributors for this article] (2019). High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases. Clinical colorectal cancer. ISSN 1533-0028. 19(1), p. 26–47. doi: 10.1016/j.clcc.2019.09.003. Full text in Research Archive
• Araghi, Marzieh; Soerjomataram, Isabelle; Bardot, Aude; Ferlay, Jacques; Cabasag, Citadel J. & Morrison, David S. [Show all 23 contributors for this article] (2019). Changes in colorectal cancer incidence in seven high-income countries: a population-based study. The Lancet Gastroenterology and Hepatology. ISSN 2468-1253. 4(7), p. 511–518. doi: 10.1016/S2468-1253%2819%2930147-5.
• Smeby, Jørgen; Sveen, Anita; Bergsland, Christian Holst; Eilertsen, Ina Andrassy; Danielsen, Stine Aske & Eide, Peter Andreas Wold [Show all 11 contributors for this article] (2019). Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer. ESMO Open. ISSN 2059-7029. 4:e000523(3), p. 1–10. doi: 10.1136/esmoopen-2019-000523. Full text in Research Archive
• Brunsell, Tuva Høst; Cengija, Vanja; Sveen, Anita; Bjørnbeth, Bjørn Atle; Røsok, Bård Ingvald & Brudvik, Kristoffer Watten [Show all 10 contributors for this article] (2019). Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases. European Journal of Surgical Oncology. ISSN 0748-7983. p. 1–7. doi: 10.1016/j.ejso.2019.07.017. Full text in Research Archive
• Rusten, Espen; Rekstad, Bernt Louni; Undseth, Christine; Klotz, Dagmar; Hernes, Eivor & Guren, Marianne Grønlie [Show all 7 contributors for this article] (2019). Anal cancer chemoradiotherapy outcome prediction using 18F-fluorodeoxyglucose positron emission tomography and clinicopathological factors. British Journal of Radiology (BJR). ISSN 0007-1285. 92:20181006(1097), p. 1–8. doi: 10.1259/bjr.20181006. Full text in Research Archive
• Smeby, Jørgen; Sveen, Anita; Eilertsen, Ina Andrassy; Danielsen, Stine Aske; Hoff, Andreas Midbøe & Eide, Peter Andreas Wold [Show all 12 contributors for this article] (2019). Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer. Oncogenesis. ISSN 2157-9024. 8:35(6), p. 1–8. doi: 10.1038/s41389-019-0141-3. Full text in Research Archive
• Røhrl, Kari; Guren, Marianne; Småstuen, Milada Cvancarova & Rustøen, Tone (2019). Symptoms during chemotherapy in colorectal cancer patients. Supportive Care in Cancer. ISSN 0941-4355. 27(8), p. 3007–3017. doi: 10.1007/s00520-018-4598-y.
• Majano, Sara Benitez; Girolamo, Chiara Di; Rachet, Bernard; Maringe, Camille; Guren, Marianne & Glimelius, Bengt [Show all 13 contributors for this article] (2018). Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study. The Lancet Oncology. ISSN 1470-2045. 20(1), p. 74–87. doi: 10.1016/S1470-2045%2818%2930646-6.
• Sodergren, Samantha C.; Johnson, Colin D.; Gilbert, Alexandra; Tomaszewski, Krzysztof A.; Chu, William & Chung, Hans T. [Show all 15 contributors for this article] (2018). Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer. Radiotherapy and Oncology. ISSN 0167-8140. 126(2), p. 222–228. doi: 10.1016/j.radonc.2017.11.018.
• Guren, Marianne; Aagnes, Bjarte; Nygård, Mari; Dahl, Olav & Møller, Bjørn (2018). Rising incidence and improved survival of anal squamous cell carcinoma in Norway, 1987-2016. Clinical colorectal cancer. ISSN 1533-0028. p. 1–8. doi: 10.1016/j.clcc.2018.10.001.
• Bruun, Jarle; Sveen, Anita; Barros, Rita; Eide, Peter Andreas Wold; Eilertsen, Ina Andrassy & Kolberg, Matthias [Show all 14 contributors for this article] (2018). Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer. Molecular Oncology. ISSN 1574-7891. 12(9), p. 1639–1655. doi: 10.1002/1878-0261.12347. Full text in Research Archive
• Claassen, Yvette H.M.; Vermeer, Nina C.A.; Iversen, Lene H.; van Eycken, Elizabeth; Guren, Marianne & Mroczkowski, Pawel [Show all 19 contributors for this article] (2018). Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison. British Journal of Cancer. ISSN 0007-0920. 119, p. 517–522. doi: 10.1038/s41416-018-0215-6.
• Vermeer, Nina C.A.; Claassen, Yvette H.M.; Derks, Marloes G.M.; Iversen, Lene H.; van Eycken, Elizabeth & Guren, Marianne [Show all 18 contributors for this article] (2018). Treatment and survival of patients with colon cancer aged 80 years and older: a EURECCA international comparison. The Oncologist. ISSN 1083-7159. 24(8), p. 982–990. doi: 10.1634/theoncologist.2017-0551.
• Smeby, Jørgen; Sveen, Anita; Merok, Marianne Aarstad; Danielsen, Stine Aske; Eilertsen, Ina Andrassy & Guren, Marianne [Show all 9 contributors for this article] (2018). CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer. Annals of Oncology. ISSN 0923-7534. 29(5), p. 1227–1234. doi: 10.1093/annonc/mdy085. Full text in Research Archive
• Byskov, Camilla; Nyvang, lars; Guren, Marianne Grønlie; Spindler, Karen-Lise Garm & Muren, Ludvig (2017). The normal tissue sparing potential of an adaptive plan selection strategy for re-irradiation of recurrent rectal cancer. Physics and imaging in radiation oncology (PIRO). ISSN 2405-6316. 3, p. 43–48. doi: 10.1016/j.phro.2017.09.001.
• Labori, Knut Jørgen; Guren, Marianne; Brudvik, Kristoffer Watten; Røsok, Bård Ingvald; Waage, Anne & Nesbakken, Arild [Show all 10 contributors for this article] (2017). Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival. Colorectal Disease. ISSN 1462-8910. 19(8), p. 731–738. doi: 10.1111/codi.13622.
• Rusten, Espen; Rekstad, Bernt Louni; Undseth, Christine; Al-Haidari, Ghazwan Ahmed Dhia Eldin; Hanekamp, Bettina & Hernes, Eivor [Show all 9 contributors for this article] (2017). Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography. Radiation Oncology. ISSN 1748-717X. 12(147), p. 1–8. doi: 10.1186/s13014-017-0883-z.
• Åsli, Linn Merete; Johannessen, Tom Børge; Myklebust, Tor Åge; Møller, Bjørn; Eriksen, Morten Tandberg & Guren, Marianne (2017). Preoperative chemoradiotherapy for rectal cancer and impact on outcomes ? A population-based study. Radiotherapy and Oncology. ISSN 0167-8140. 123(3), p. 446–453. doi: 10.1016/j.radonc.2017.04.012.
• Thomsen, Maria; Guren, Marianne; Skovlund, Eva; Glimelius, Bengt; Hjermstad, Marianne Jensen & Johansen, Julia S. [Show all 12 contributors for this article] (2017). Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status. European Journal of Cancer. ISSN 0959-8049. 81, p. 26–35. doi: 10.1016/j.ejca.2017.04.026.
• Astrup, Guro Lindviksmoen; Hofsø, Kristin; Bjordal, Kristin; Guren, Marianne; Vistad, Ingvild & Cooper, Bruce [Show all 8 contributors for this article] (2017). Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence. Acta Oncologica. ISSN 0284-186X. 56(3), p. 462–470. doi: 10.1080/0284186X.2016.1273546.
• Røhrl, Kari; Guren, Marianne; Miaskowski, Christine; Cooper, Bruce A.; Diep, Lien My & Rustøen, Tone (2016). No Differences in Symptom Burden Between Colorectal Cancer Patients Receiving Curative Versus Palliative Chemotherapy. Journal of Pain and Symptom Management. ISSN 0885-3924. 52(4), p. 539–547. doi: 10.1016/j.jpainsymman.2016.04.008.
• Cameron, Marte; Kersten, Christian; Vistad, Ingvild; van Helvoirt, Rene; Weyde, Kjetil & Undseth, Christine [Show all 10 contributors for this article] (2016). Palliative pelvic radiotherapy for symptomatic rectal cancer–a prospective multicenter study. Acta Oncologica. ISSN 0284-186X. 55(12), p. 1400–1407. doi: 10.1080/0284186X.2016.1191666.
• Glimelius, Bengt; Myklebust, Tor Åge; Lundqvist, Kristina; Wibe, Arne & Guren, Marianne (2016). Two countries – Two treatment strategies for rectal cancer. Radiotherapy and Oncology. ISSN 0167-8140. 121(3), p. 357–363. doi: 10.1016/j.radonc.2016.11.010.
• Leon, Otilia; Guren, Marianne; Radu, Calin; Gunnlaugsson, Adalsteinn & Johnsson, Anders (2015). Phase i study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer. European Journal of Cancer. ISSN 0959-8049. 51(18), p. 2740–2746. doi: 10.1016/j.ejca.2015.08.029.
• Labori, Knut Jørgen; Schulz, Anselm; Drolsum, Anders; Guren, Marianne; Kløw, Nils-Einar & Bjørnbeth, Bjørn Atle (2015). Radiofrequency ablation of unresectable colorectal liver metastases: trends in management and outcome during a decade at a single center. Acta Radiologica Open. ISSN 2058-4601. 4(7), p. 1–9. doi: 10.1177/2058460115580877.
• Guren, Marianne; Kørner, Hartwig; Pfeffer, Frank; Myklebust, Tor Åge; Eriksen, Morten Tandberg & Edna, Tom-Harald [Show all 23 contributors for this article] (2015). Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. Acta Oncologica. ISSN 0284-186X. 54(10), p. 1714–1722. doi: 10.3109/0284186X.2015.1034876.
• Walters, Sarah; Benitez-Majano, Sara; Muller, Patrick; Coleman, Michel P.; Allemani, Claudia & Butler, John [Show all 12 contributors for this article] (2015). Is England closing the international gap in cancer survival? British Journal of Cancer. ISSN 0007-0920. 113(5), p. 848–860. doi: 10.1038/bjc.2015.265.
• Cameron, Marte; Kersten, Christian; Vistad, Ingvild; van Helvoirt, Rene; Weyde, Kjetil & Undseth, Christine [Show all 10 contributors for this article] (2015). Palliative pelvic radiotherapy for symptomatic incurable prostate cancer - A prospective multicenter study. Radiotherapy and Oncology. ISSN 0167-8140. 115(3), p. 314–320. doi: 10.1016/j.radonc.2015.05.021. Full text in Research Archive
• Leon, Otilia; Guren, Marianne; Hagberg, Oskar; Glimelius, Bengt; Dahl, Olav & Havsteen, Hanne [Show all 17 contributors for this article] (2014). Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines. Radiotherapy and Oncology. ISSN 0167-8140. 113(3), p. 352–358. doi: 10.1016/j.radonc.2014.10.002.
• Guren, Marianne; Undseth, Christine; Rekstad, Bernt Louni; Brandengen, Morten; Dueland, Svein & Spindler, Karen-Lise Garm [Show all 8 contributors for this article] (2014). Reirradiation of locally recurrent rectal cancer: A systematic review. Radiotherapy and Oncology. ISSN 0167-8140. 113(2), p. 151–157. doi: 10.1016/j.radonc.2014.11.021.
• Cameron, Marte Grønlie; Kersten, Christian; Guren, Marianne; Fosså, Sophie Dorothea & Vistad, Ingvild (2014). Palliative pelvic radiotherapy of symptomatic incurable prostate cancer - A systematic review. Radiotherapy and Oncology. ISSN 0167-8140. 110(1), p. 55–60. doi: 10.1016/j.radonc.2013.08.008.
• Cameron, Marte; Kersten, Christian; Vistad, Ingvild; Fosså, Sophie Dorothea & Guren, Marianne (2014). Palliative pelvic radiotherapy of symptomatic incurable rectal cancer - a systematic review. Acta Oncologica. ISSN 0284-186X. 53(2), p. 164–173. doi: 10.3109/0284186X.2013.837582.
• Sveen, Anita; Nesbakken, Arild; Ågesen, Trude Holmeide; Guren, Marianne; Tveit, Magne Kjell & Skotheim, Rolf Inge [Show all 7 contributors for this article] (2013). Anticipating the Clinical Use of Prognostic Gene Expression-Based Tests for Colon Cancer Stage II and III: Is Godot Finally Arriving? Clinical Cancer Research. ISSN 1078-0432. 19(24), p. 6669–6677. doi: 10.1158/1078-0432.CCR-13-1769.
• Bentzen, Anne Gry; Guren, Marianne; Vonen, Barthold; Wanderås, Eva Hoff; Frykholm, Gunilla & Wilsgaard, Tom [Show all 8 contributors for this article] (2013). Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort. Radiotherapy and Oncology. ISSN 0167-8140. 108(1), p. 55–60. doi: 10.1016/j.radonc.2013.05.037.
• Bentzen, Anne Gry; Balteskard, Lise; Wanderås, Eva Hoff; Frykholm, Gunilla; Wilsgaard, Tom & Dahl, Olav [Show all 7 contributors for this article] (2013). Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors. Acta Oncologica. ISSN 0284-186X. 52(4), p. 736–744. doi: 10.3109/0284186X.2013.770599.
• Amdal, Bente Cecilie Delphin; Jacobsen, Anne-Birgitte; Guren, Marianne & Bjordal, Kristin (2013). Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: A systematic review. Acta Oncologica. ISSN 0284-186X. 52(4), p. 679–690. doi: 10.3109/0284186X.2012.731521.
• Sorbye, Halfdan; Welin, Staffan; Langer, Seppo W.; Vestermark, Lene Weber; Holt, Nanna & Osterlund, Pia [Show all 20 contributors for this article] (2013). Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study. Annals of Oncology. ISSN 0923-7534. 24(1), p. 152–160. doi: 10.1093/annonc/mds276.
• Bentzen, Anne Gry; Guren, Marianne; Wanderås, Eva Hoff; Frykholm, Gunilla; Tveit, Magne Kjell & Wilsgaard, Tom [Show all 8 contributors for this article] (2012). Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National Cohort. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 83(2), p. E173–E180. doi: 10.1016/j.ijrobp.2011.12.062.
• Balteskard, Lise; Dahl, Olav; Guren, Marianne; Haraldsen, Mathilde; Strickert, Trond & Wanderås, Eva Hoff [Show all 9 contributors for this article] (2011). Faglige anbefalinger for behandling ved analcancer. StrålevernRapport. ISSN 0804-4910. 5, p. 1–34.
• BRUHEIM, KJERSTI; Guren, Marianne; Skovlund, Eva; Hjermstad, Marianne Jensen; Dahl, Olav & Frykholm, Gunilla [Show all 8 contributors for this article] (2010). Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 76(4), p. 1005–1011. doi: 10.1016/j.ijrobp.2009.03.010.
• Bruheim, Kjersti; Tveit, Magne Kjell; Skovlund, Eva; Balteskard, Lise; Carlsen, Erik & Fosså, Sophie Dorothea [Show all 7 contributors for this article] (2010). Sexual function in females after radiotherapy for rectal cancer. Acta Oncologica. ISSN 0284-186X. 49(6), p. 826–832. doi: 10.3109/0284186X.2010.486411.
• Bruheim, Kjersti; Guren, Marianne; Dahl, Alv A; Skovlund, Eva; Balteskard, Lise & Carlsen, Erik [Show all 8 contributors for this article] (2010). Sexual function in males after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 76(4), p. 1012–1017. doi: 10.1016/j.ijrobp.2009.03.075.
• Bruheim, K; Guren, MG; Skovlund, E; Hjermstad, Marianne Jensen; Dahl, O & Frykholm, Gunilla [Show all 8 contributors for this article] (2010). Late side effects and quality of life after radiotherapy for rectal cancer. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 76(4), p. 1005–1011. doi: 10.1016/j.ijrobp.2009.03.010.
• Marienhagen, Kirsten; Helland, Åslaug; Nordberg, Terje; Guren, Marianne Grønlie & Hofsli, Eva (2010). Hva mener norske onkologer om sin arbeidssituasjon? Tidsskrift for Den norske legeforening. ISSN 0029-2001. 130(5), p. 487–489. doi: 10.4045/tidsskr.08.0305.
• Bruheim, Kjersti; Svartberg, Johan; Carlsen, Erik; Dueland, Svein; Haug, Egil & Skovlund, Eva [Show all 8 contributors for this article] (2008). Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH. International Journal of Radiation Oncology, Biology, Physics. ISSN 0360-3016. 70(3), p. 722–727. doi: 10.1016/j.ijrobp.2007.10.043.

View all works in Cristin

• Grøndahl, Aurora Rosvoll; Huynh, Bao Ngoc; Moe, Yngve Mardal; Kaushal, Christine Kiran; Rusten, Espen & Tomic, Oliver [Show all 13 contributors for this article] (2021). Deep learning for automatic target volume delineation .
• Grøndahl, Aurora Rosvoll; Huynh, Bao Ngoc; Moe, Yngve Mardal; Kaushal, Christine Kiran; Rusten, Espen & Tomic, Oliver [Show all 12 contributors for this article] (2021). Deep learning-based automatic delineation of anal cancer gross tumour volume: A multimodality comparison of CT,PET and MRI.
• Grøndahl, Aurora Rosvoll; Huynh, Bao Ngoc; Moe, Yngve Mardal; Kaushal, Christine Kiran; Rusten, Espen & Tomic, Oliver [Show all 12 contributors for this article] (2021). Deep learning-based automatic delineation of anal cancer gross tumour volume: A multimodality comparison of CT, PET and MRI.
• Kalsnes, Joakim; Rusten, Espen; Abravan, Azadeh; Rekstad, Bernt Louni; Hernes, Eivor & Guren, Marianne [Show all 7 contributors for this article] (2019). Assessment of hematologic toxicity by 18F-fluorodeoxyglucose PET/CT in anal cancer patients following chemoradiation.
• Kørner, Hartwig; Guren, Marianne; Søreide, Jon Arne; Kørner, Leif; Søreide, Kjetil & Kvaløy, Jan Terje [Show all 7 contributors for this article] (2019). Non-curative treatment of patients with colorectal cancer – a national cohort study.
• Rusten, Espen; Rekstad, Bernt Louni; Undseth, Christine; Hernes, Eivor; Hanekamp, Bettina & Guren, Marianne [Show all 7 contributors for this article] (2019). Medical imaging of anal cancer and image-guided radiotherapy strategies .
• Kalsnes, Joakim; Rusten, Espen; Abravan, Azadeh; Rekstad, Bernt Louni; Hernes, Eivor & Guren, Marianne [Show all 7 contributors for this article] (2019). FDG-PET/CT-based assessment of hematologic toxicity in anal cancer patients following chemoradiation. Radiotherapy and Oncology. ISSN 0167-8140. 133, p. 1112–1112.
• Skingen, Vilde Eide; Rusten, Espen; Rekstad, Bernt Louni; Undseth, Christine; Guren, Marianne & Malinen, Eirik (2018). A patient-specific tumor control probability model based on total lesion glycolysis of anal cancer. Radiotherapy and Oncology. ISSN 0167-8140. 127, p. 1088–1088.
• Rusten, Espen; Rekstad, Bernt Louni; Undseth, Christine; Hernes, Eivor; Guren, Marianne & Malinen, Eirik (2018). Prediction of anal carcinoma chemoradiotherapy outcome by a new PET-based biomarker. Radiotherapy and Oncology. ISSN 0167-8140. 127, p. 814–814.
• Støen, Ingvild; Rusten, Espen; Rekstad, Bernt Louni; Undseth, Christine; Al-Haidari, Ghazwan Ahmed Dhia Eldin & Hellebust, Taran Paulsen [Show all 8 contributors for this article] (2017). Optimal threshold for PET-based autocontouring of boost volume for radiotherapy of anal carcinoma.
• Skingen, Vilde Eide; Rekstad, Bernt Louni; Rusten, Espen; Undseth, Christine; Hellebust, Taran Paulsen & Guren, Marianne [Show all 7 contributors for this article] (2017). PET-based dose painting of anal carcinoma and implications for adaptive approaches.
• Malinen, Eirik; Rusten, Espen; Hernes, Eivor & Guren, Marianne (2017). Positron emission tomography in radiotherapy of anal cancer.
• Rusten, Espen; Rekstad, Bernt Louni; Undseth, Christine; Al-Haidari, Ghazwan Ahmed Dhia Eldin; Hanekamp, Bettina & Hernes, Eivor [Show all 9 contributors for this article] (2016). Target delineation of anal cancer based on MR or PET – an inter-observer, inter-modality study. Radiotherapy and Oncology. ISSN 0167-8140. 119, p. 336–337.
• Malinen, Eirik & Guren, Marianne (2016). Forskning innen bildeveiledet strålebehandling av analkreft.
• Røhrl, Kari; Guren, Marianne & Rustøen, Tone (2015). Symptom burden in colorectal cancer patient at start of chemotherapy.
• Rusten, Espen; Rekstad, Bernt Louni; Undseth, Christine; Hernes, Eivor; Guren, Marianne & Malinen, Eirik (2015). Early radiotherapy response monitoring of anal carcinoma with 18F-FDG-PET.
• Rekstad, Bernt Louni; Rusten, Espen; Undseth, Christine; Arnesen, Marius Røthe; Hellebust, Taran Paulsen & Holmboe, Laila Kampen Dajani [Show all 8 contributors for this article] (2015). Anal carcinoma – a candidate for FDG-PET guided high-dose simultaneously integrated boost .
• Sorbye, Halfdan; Welin, Staffan; Langer, Seppo; Vestermark, Lena; Holt, Nanna & Osterlund, Pia [Show all 20 contributors for this article] (2013). Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3). Pancreas. ISSN 0885-3177. 42(2), p. 382–382.
• Sorbye, Halfdan; Welin, Staffan; Langer, Seppo W.; Vestermark, Lene Weber; Holt, Nanna & Osterlund, Pia J. [Show all 20 contributors for this article] (2012). Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal poorly differentiated neuroendocrine carcinoma: The NORDIC NEC study. Journal of Clinical Oncology. ISSN 0732-183X. 30(15).
• BRUHEIM, KJERSTI & Guren, Marianne (2010). Late side effects and quality of life after radiotherapy for rectal cancer. Unipub forlag.

View all works in Cristin